Conference Coverage

Fasting glucose fluctuations, severe hypoglycemia up T2DM death risk

Publish date: October 3, 2017

 

Pages

Recommended Reading

AWARD-7: Dulaglutide benefits patients with diabetic renal disease
MDedge Internal Medicine
Obtaining cystatin-C levels useful in chronic kidney disease
MDedge Internal Medicine
No increased overall cardiovascular risk seen with exenatide use
MDedge Internal Medicine
Alirocumab’s ODYSSEY continues: Efficacy unaffected by insulin, beats fenofibrate
MDedge Internal Medicine
Roux-en-Y gastric bypass produced durable clinical improvements at 12 years
MDedge Internal Medicine
Empagliflozin’s effects independent of CVD risk factors
MDedge Internal Medicine
Delayed-release metformin proves promising for diabetic renal disease
MDedge Internal Medicine
FDA approves first non–finger-stick glucose monitoring system
MDedge Internal Medicine
New ADA hypertension and diabetes treatment guide features visual aid
MDedge Internal Medicine
Many years on metformin linked to anemia risk
MDedge Internal Medicine